Medications for Colorectal Neoplasms

15 results

  • capecitabine

    (Capecitabine)
    Areva Pharmaceuticals
    Capecitabine is indicated for adjuvant treatment of Dukes’ C colon cancer post-surgery and as a first-line treatment for metastatic colorectal carcinoma. It is also used with docetaxel for metastatic breast cancer after prior anthracycline failure and as monotherapy for resistant metastatic breast cancer.

  • capecitabine

    (capecitabine)
    BluePoint Laboratories
    Capecitabine is indicated for the treatment of various cancers, including Stage III colon cancer, locally advanced rectal cancer, unresectable or metastatic colorectal cancer, advanced or metastatic breast cancer, and unresectable or metastatic gastric and pancreatic cancers, often in combination with other chemotherapy agents.

  • capecitabine

    (CAPECITABINE)
    NorthStar RxLLC
    Capecitabine is indicated for adjuvant treatment of Dukes' C colon cancer post-surgery and as first-line therapy for metastatic colorectal carcinoma. It is also used in combination with docetaxel for metastatic breast cancer after anthracycline failure, or as monotherapy for patients resistant to paclitaxel and anthracyclines.

  • capecitabine

    (Capecitabine)
    Aurobindo Pharma Limited
    Capecitabine tablets are indicated for the treatment of Stage III colon cancer, locally advanced rectal cancer, unresectable or metastatic colorectal cancer, advanced or metastatic breast cancer, unresectable gastric or esophageal cancers, and as adjuvant therapy for pancreatic adenocarcinoma in combination with chemotherapy regimens.

  • capecitabine 150mg

    (Capecitabine)
    Armas Pharmaceuticals Inc.
    Capecitabine tablets are indicated for adjuvant treatment of Dukes' C colon cancer post-surgery and as first-line therapy for metastatic colorectal carcinoma. They are also used for metastatic breast cancer after anthracycline failure, both in combination with docetaxel and as monotherapy for resistant cases.

  • leucovorin calcium

    (leucovorin calcium)
    Slate Run Pharmaceuticals, LLC
    Leucovorin calcium is indicated for rescue after high-dose methotrexate therapy in osteosarcoma, to reduce toxicity from methotrexate overdosage, treat megaloblastic anemia due to folic acid deficiency, and as an adjunct with 5-fluorouracil in palliative treatment of advanced colorectal cancer.

  • leucovorin calcium

    (leucovorin calcium)
    Sagent Pharmaceuticals
    Leucovorin calcium is indicated as a rescue therapy after high-dose methotrexate in osteosarcoma, to reduce toxicity from methotrexate or folic acid antagonist overdosage, treat megaloblastic anemias, and enhance survival in advanced colorectal cancer when used with 5-fluorouracil (separate infusions needed).

  • oxaliplatin

    (Oxaliplatin)
    Sun Pharmaceutical Industries, Inc.
    Oxaliplatin for injection USP is indicated for the adjuvant treatment of stage III colon cancer post-surgery and for the treatment of advanced colorectal cancer, in combination with infusional 5-fluorouracil/leucovorin.

  • oxaliplatin

    (Oxaliplatin)
    Sandoz Inc
    Oxaliplatin injection, combined with infusional fluorouracil and leucovorin, is indicated for the adjuvant treatment of stage III colon cancer post-complete tumor resection and for the treatment of advanced colorectal cancer.

  • oxaliplatin

    (Oxaliplatin)
    Fosun Pharma USA Inc.
    Oxaliplatin Injection, USP is indicated for adjuvant treatment of stage III colon cancer post-surgery and for the treatment of advanced colorectal cancer, when used in combination with infusional 5-fluorouracil/leucovorin.